These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1123459)

  • 21. [Diffusion of aspirin and its metabolites through the synovial membrane].
    Bannwarth B; Netter P; Pourel J; Royer-Morot MJ; Royer RJ; Gaucher A
    Rev Rhum Mal Osteoartic; 1985 May; 52(5):333-6. PubMed ID: 4012212
    [No Abstract]   [Full Text] [Related]  

  • 22. Disappearance kinetics of solutes from synovial fluid after intra-articular injection.
    Owen SG; Francis HW; Roberts MS
    Br J Clin Pharmacol; 1994 Oct; 38(4):349-55. PubMed ID: 7833225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sulphydryl groups in the synovial fluid in cases of rheumatoid arthritis, reactive synovitis of local origin and in post-mortem synovial fluid.
    Hrncír Z; Tichý M; Salavec M; Vavrina J
    Rev Czech Med; 1974; 20(1):34-8. PubMed ID: 4815840
    [No Abstract]   [Full Text] [Related]  

  • 24. Angiogenic factor from synovial fluid resembling that from tumours.
    Brown RA; Weiss JB; Tomlinson IW; Phillips P; Kumar S
    Lancet; 1980 Mar; 1(8170):682-5. PubMed ID: 6103093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative tissue absorption of oral 14C-aspirin and topical triethanolamine 14C-salicylate in human and canine knee joints.
    Rabinowitz JL; Feldman ES; Weinberger A; Schumacher HR
    J Clin Pharmacol; 1982 Jan; 22(1):42-8. PubMed ID: 6977559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyaluronic acid in human synovial effusions; a sensitive indicator of altered connective tissue cell function during inflammation.
    Castor CW; Prince RK; Hazelton MJ
    Arthritis Rheum; 1966 Dec; 9(6):783-94. PubMed ID: 5297217
    [No Abstract]   [Full Text] [Related]  

  • 27. The passage of benorylate into the synovial fluid and tissue of rheumatoid patients.
    Laine VA; Penn RG; Pätiälä H; Sibelius R
    Scand J Rheumatol Suppl; 1975; 13():18-20. PubMed ID: 8834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombin in synovial fluid as a marker of synovial inflammation: a definite measurement by ELISA and correlation with VEGF.
    Kitamoto Y; Nakamura E; Kudo S; Tokunaga H; Murakami E; Noguchi K; Imamura T
    Clin Chim Acta; 2008 Dec; 398(1-2):159-60. PubMed ID: 18765237
    [No Abstract]   [Full Text] [Related]  

  • 29. Study on the fractionation of synovial fluid protein.
    Kim WJ; Ahn YS; Kim SJ; Jahng JS; Hong SS
    Yonsei Med J; 1976; 17(2):109-14. PubMed ID: 1030559
    [No Abstract]   [Full Text] [Related]  

  • 30. Levels of immunoglobulin E (IgE) in paired examinations of serum and synovial fluid in rheumatoid arthritis and reactive synovitis of local origin.
    Hrncír Z; Tichý M; Sims J; Salavec M; Vavrina J
    Clin Chim Acta; 1977 Dec; 81(3):293-8. PubMed ID: 923104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein traffic in human synovial effusions.
    Wallis WJ; Simkin PA; Nelp WB
    Arthritis Rheum; 1987 Jan; 30(1):57-63. PubMed ID: 3814198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transsynovial kinetics of lonazolac and its hydroxy metabolite in synovitis patients.
    Deneke J; Luckow V; Guserle R; Pässler HH
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):418-24. PubMed ID: 9726694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synovial fluid crystals.
    Dieppe PA; Crocker PR; Corke CF; Doyle DV; Huskisson EC; Willoughby DA
    Q J Med; 1979 Oct; 48(192):533-53. PubMed ID: 231795
    [No Abstract]   [Full Text] [Related]  

  • 34. Tryptophan metabolism in the joint diseases.
    Igari T; Obara K; Ono S; Toba Y
    Acta Vitaminol Enzymol; 1975; 29(1-6):194-7. PubMed ID: 1244092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma and synovial fluid concentrations of acetylsalicylic acid in patients with rheumatoid arthritis.
    Sholkoff SD; Eyring EJ; Rowland M; Riegelman S
    Arthritis Rheum; 1967 Aug; 10(4):348-51. PubMed ID: 6046016
    [No Abstract]   [Full Text] [Related]  

  • 36. Lack of relationship between synovial fluid and systemic inflammatory pattern in elderly-onset rheumatoid arthritis.
    Marson P; Cavasin F; Punzi L; Gambari PF
    Clin Exp Rheumatol; 1989; 7(6):663-4. PubMed ID: 2692896
    [No Abstract]   [Full Text] [Related]  

  • 37. Keratan sulfate in body fluids in joint disease.
    Thonar EJ; Masuda K; Häuselmann HJ; Uebelhart D; Lenz ME; Manicourt DH
    Acta Orthop Scand Suppl; 1995 Oct; 266():103-6. PubMed ID: 8553836
    [No Abstract]   [Full Text] [Related]  

  • 38. Simultaneous pharmacokinetics of benorylate in plasma and synovial fluid of patients with rheumatoid arthritis.
    Aylward M; Maddock J; Rees P; Thomas GM; Wheeldon R; Holly F
    Scand J Rheumatol Suppl; 1975; 13():9-12. PubMed ID: 8841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetics of aurothiomalate in serum and synovial fluid.
    Gerber RC; Paulus HE; Bluestone R; Lederer M
    Arthritis Rheum; 1972; 15(6):625-9. PubMed ID: 4628732
    [No Abstract]   [Full Text] [Related]  

  • 40. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control.
    Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A
    Arthritis Res Ther; 2005; 7(4):R817-24. PubMed ID: 15987483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.